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SUMMARY 
Canine parvovirus enteritis affects predominantly puppies with a high prevalence rate in Nigeria 
and is characterized by diarrhea, vomiting, anorexia and leucopenia. Treatment is non-specific; 
hence array of medications are usually prescribed to manage the condition symptomatically. 
Irrational drugs prescription has been reported to be one of the causes of therapeutic failures and 
adverse drug reactions in veterinary medicine. This study was therefore designed to evaluate the 
pattern of drugs prescription in dogs diagnosed with parvovirus enteritis in some small animal 
clinics in Nigeria. The study was carried out in 10 states of Nigeria and Abuja. A retrospective 
study of drugs prescription pattern in dogs diagnosed with CPE, including polypharmacy, 
prescription rates, and dose regimen of gentamicin in 20 veterinary clinics were conducted from 
January, 2010 to December, 2014. Results showed that 554 (80.6%) of 687 patients were 
administered ≥4 drugs per encounter. Of the 2,482 drugs prescribed at the different clinics, 
antibiotics had the highest prescription rate of 42.3% (1,050). Gentamicin was the most 
frequently prescribed antibiotic which accounted for 23.8% (250) prescription rate. However, 
57.2% (143) of the patients were under-dosed (<6mg/kg). Also, non-essential prescription of 
non-steroidal anti-inflammatory and gastrointestinal modulating drugs, including ranitidine were 
observed. This study has demonstrated that most drug prescriptions for dogs with parvovirus 
enteritis in Nigeria are inappropriate. This could have contributed to poor therapeutic outcomes 
common in parvovirus enteritis management. Consequently, Veterinarians should be rational in 
drugs prescription in order to optimize therapeutic efficacy and minimize adverse drug effects. 
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INTRODUCTION 
Canine parvovirus enteritis (CPE) is a highly 
contagious disease affecting predominantly 
young dogs caused by canine parvovirus 
which is transmitted through direct or 
indirect contact with contaminated feces or 
fomites (Appel et al., 1979; Kahn, 2010). It 
is characterized by vomiting, diarrhea, 
lethargy, hypoglycemia and leucopenia 
(Streck et al., 2009). In spite of the 
prophylactic measures and various treatment 
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protocols described for CPE, its prevalence 
is still high in Nigeria (Shima et al., 2015). 
Survival rates have been reported to be as 
high as 80-95% when managed early and 
aggressively, but as low as 9.1% in the 
absence of adequate management (Prittie, 
20045; Goddard and Leisewitz, 2010). 
Currently, there is no specific treatment for 
this viral condition; however, good survival 
rate can be achieved with appropriate 
supportive and symptomatic management 
(Boothe, 2012). Consequently, management 
is tailored towards treating symptoms 
associated with the disease while the virus 
runs its course. This management involves 
prescription of an array of medications, in 
addition to supportive nutrition. 
Irrational drug prescriptions by clinicians 
have been reported to be a common practice 
in most developing countries (Isenalumehe 
and Oviawe, 1988; Laing, 1990). Rational 
use of drugs requires that patients receive 
medications appropriate to their clinical 
needs, in doses that meet their individual 
requirements for an adequate period of time 
and at the lowest cost to the client (WHO, 
1993). This has been reported to reduce 
therapeutic failures, cost of treatment and 
adverse effects (Pramil, 2012). Thus, 
increased awareness of rational drugs 
prescription is essential to minimize adverse 
effects and optimize therapeutic outcomes. 
There is paucity of information on the 
prescription pattern of drugs in small animal 
practice in Nigeria. The objective of this 
study was to evaluate the pattern of drugs 
prescription in dogs diagnosed with CPE in 
some small animal clinics in Nigeria. 
 
MATERIALS AND METHODS 
Study Locations 
This study was conducted in 10 states and 
Abuja (Federal Capital Territory). The 
inclusion criterion for each study location 
was based on high level of small animal 
practice. A total of 20 small animal clinics 
were included in this study comprising of 7 
state owned veterinary clinics, 10 private 
veterinary clinics and 3 Veterinary Teaching 
Hospitals. The informed consent of the head 




The study was a retrospective cross-
sectional case analysis where clinical data 
were extracted from case records between 
January, 2010 and December, 2014. Cases 
inclusion criterion was dogs that were 
diagnosed with CPE based on either 
presumptive and/or laboratory diagnoses. 
Data obtained from individual case record 
files included patients’ characteristics such 
as age, body weight, breed and sex. In 
addition, details of medications for each 
patient, including drugs administered, and 
diagnostic methods were extracted. 
Furthermore, the dosage regimen data such 
as dose/amount, frequency, duration and 
routes of administration of gentamicin for 
each patient per encounter was obtained 
from the clinical records. 
Data were analyzed employing the method 
earlier described by Shea et al. (2011). The 
average number of drugs prescribed per 
encounter was computed to measure the 
degree of polypharmacy. This was done by 
dividing the total number of different drug 
products prescribed or administered by the 
total number of encounters. The prescription 
rate of drug by category and subsequent 
individual drugs in a category were obtained 
by dividing the number of patient encounters 
in which the class of drug was prescribed or 
administered by the total number of 
encounters surveyed. Also, the number of 
encounters in which the correct dose of 
injectable gentamicin was administered was 
obtained in order to measure the correctness 
of gentamicin medication. 
 
RESULTS 
Extraction of the reported cases of CPE 
between January, 2010 and December, 2014 
from 20 small animal clinics in some parts 
of Nigeria yielded 704 cases. Of these, only 
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35 (5%) were diagnosed with CPE 
using canine parvovirus antigen test kit 
(rapid Enzyme chromatographic 
immunosorbent assay), whereas 609 
(95%) were diagnosed presumptively 
based on circumstantial evidence such 
as age, vaccination history, exposure, 
vomiting, diarrhea and dehydration. 
Figure 1 illustrates extent of 
polypharmacy in the management of 
CPE in dogs during the period under 
review in some veterinary 
clinics/hospitals in the studied 
locations. Of the 687 cases reviewed, 
133 (19.4%) were treated with less 
than 4 different drugs per encounter, 
whereas 461(67.1%) were at a single 
encounter, treated with 4-6 different 
drugs. On a single encounter, 90 
(13.1%) and 3 (0.4%) of the patients 
were given 7-10 and more than 10 
different drugs, respectively. 
Figure 2 shows that of the 2,482 drugs 
prescribed during the period, 
antimicrobial agents (AMC) were the 
most frequently prescribed, accounting 
for the prescription rate of 42.3% 
(1,050) followed by vitamins and 
minerals (VMS) which accounted for 
25.3% (628) of the total prescriptions. 
The result also shows that anthelmintic 
(AHE), antiemetics (AEM), and 
gastrointestinal modulating drugs 
(GIM) accounted for 16.0% (398),  
 
 
 Figure 1: Polypharmacy practice in dogs on 
parvovirus enteritis management in some veterinary 




 Figure 2: Category-wise drug prescription rates in 
dogs on parvovirus enteritis management in some 
small animal clinics in Nigeria from January, 2010 to 
December, 2014 
 Index: AMC (antimicrobial), AHE (anthelmintics), 
AEM (antiemetics), ANG (analgesics), ASG (anti-
sialogogues), GIM (gastrointestinal modulators), 
VMS (vitamins and minerals), IMG 
(immunomodulators) 
8.6% (216) and 3.3% (83) of the prescribed 
drugs, respectively. Furthermore, 2.6% (65), 
1.7% (41) and 0.2% (4) of the total 
prescriptions were anti-sialogogues (ASG), 
analgesics (ANG) and immunoglobulin 
(IMG), respectively. Individual 
antimicrobial agents prescribed for dogs 
with CPE within the study period are shown 
in Figure 3. This result shows that of the 
1050 antimicrobial agents prescribed to the 
study population, gentamicin (GEN) was the 
most frequently prescribed with a 
prescription rate of 23.8% (250), closely 
followed by metronidazole (MET) and 
oxytetracycline (OTC) which accounted for 
20.0% (210) and 17.6% (186) prescription 
rates, respectively. Amoxicillin (AMX), 
sulphadimidine (SUP) and trimethoprim 
(TMP) accounted for 12.6% (132), 6.5% 
(68) and 4.7% (39), respectively. The 7 least 
prescribed antimicrobial agents in this 
population were penicillin (PEN) alone or 
with streptomycin (PES), enrofloxacin 
(ENR), amikacin (AMK), ceftriaxone 
(CET), chloramphenicol (CAM) and 
cefuroxime (CEF), each with a prescription 
rate less than 2.0%.  
Result in Figure 4 shows that the most 
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28.0% (23), 9.0% 
(8) and 5.0% (4), 
respectively.  
Of the 41 
prescriptions of 
analgesics for 
puppies with CPE,  
 
 
 Figure 3: Prescription frequencies of antibiotics in dogs on parvovirus 
enteritis management in some small animal clinics in Nigeria from 
January, 2010 to December, 2014 (n=1050) 
 Index: AMC (amoxicillin/clavulanate), AMK (amikacin), AMP 
(ampicillin), AMX (amoxicillin), CAM (chloramphenicol), CEF 
(cefuroxime), CET (ceftriaxone), CIP (ciprofloxacin), CLT 
(chlortetracycline), ENR (enrofloxacin), GEN (gentamicin), MET 
(metronidazole), OTC (oxytetracycline), PEN (penicillin), PES 
(penicillin/strepomycin), TMP (trimethoprim), SUP (Sulphadimidine) 
68.0% (28) were 
piroxicam (PRX) 
injectable, 29.0% (12) 
diclofenac (DCF) 
injectable and 3.0% (1) 
was ibuprofen (IBF) 
tablet (Figure 5). 
Result of gentamicin dose 
per body weight (mg/kg) 
in dogs on CPE 
management within the 
period under review is 
presented in Figure 6. Of 
the 250 gentamicin  
 
 
 Figure 4: Prescription rate of gastrointestinal modulators for dogs 
with parvovirus enteritis in some veterinary clinics in Nigeria 
from January, 2010 to December, 2014 
 Index: MK (mist kaolin), LOM (lomotil), RANITID (ranitidine) 
prescriptions, 57.0% (143) and 30.0% (74) 
accounted for doses less than 6mg/kg and 6-
9 mg/kg, respectively. In addition, 6.0% (14) 
and 7.0% (19) of the prescriptions were 
administered at dose levels of 10-12mg/kg 
and above 12mg/kg, respectively. The 




Multiple drug prescription (polypharmacy) 
has been reported to increase the risk of 
adverse drug-drug interactions, therapeutic 
failure and increase in the cost of treatment 
(Zuckermann, 2007; Bjerrum and Gonzalez, 
2008; Kirsten et al., 2010). This study 
revealed that 67.1% of the patients were 
administered 4-6 different drugs per 
encounter which is above the recommended 
limit of 2 at a time for human (Isah et al., 
2004). No such limit has been set for 
animals; however, the objective of this limit 
in human is simply to reduce drug-drug 
interactions and the effects on safety and 
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which applies to 
animals as well. In 
human patients with 
unspecified clinical 
conditions in Nigeria, 
3.0-3.8 drugs per 
prescription have been 
reported (Tamuno and 
Fadare, 2012) which is 
comparable to our 
finding in dogs 
diagnosed with CPE. 
Consequently, 
polypharmacy, as 
demonstrated in this 
study could increase the 
risk of drug interactions 
and treatment cost. This 
may perhaps result in 
medication cascade 
effect as well as 
therapeutic duplication 
errors. This could have 
contributed to the poor 
therapeutic outcomes 
common in CPE 
management. However, 
polypharmacy is often 
associated with the 
management of 
critically ill patients  
 
 
 Figure 5: Prescription rates of analgesics in dogs with parvovirus 
enteritis in some veterinary clinics in Nigeria 
 Index: DCF (diclofenac), IBF (ibuprofen), PRX (piroxicam) 
 
 
 Figure 6: Gentamicin dosages in dogs on parvovirus enteritis 
management in some small animal clinics in Nigeria from January, 
2010 to December, 2014 
where several drugs are used concomitantly 
to alleviate associated symptoms (Veehof et 
al., 2000). This is applicable to CPE patients 
where the aim is usually to manage a range 
of clinical symptoms associated with the 
illness, such as diarrhea, vomiting, 
secondary bacterial infections and pains. 
Consequently, fluids and electrolytes, anti-
diarhoeics, antiemetics, antibiotics and 
analgesics are frequently and concurrently 
required for effective management of this 
condition (Appel et al., 1979). It is evident 
that polypharmacy is inevitable in CPE 
patients; nevertheless, considering the 
associated increased risk of adverse drug 
reactions that rises exponentially with the 
number of concomitant drugs used and 
interactions that may blur the intended 
effects of the drugs on the disease, the 
choice of drugs and dosage regimens must 
be appropriate and prudent. 
There is currently no specific treatment 
against CPE, nonetheless, good survival 
rates could be achieved with appropriate 
supportive treatment protocols involving 
different categories of drugs. This study 
shows that prescription rate of 
antimicrobials in dogs diagnosed with 
parvovirus enteritis ranked highest amongst 
other drug categories within the period 
under review (January, 2010 - December, 
2014). This gives credence to an earlier 
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report that antimicrobial agents remain one 
of the most frequently prescribed drugs in 
human and veterinary medicine worldwide, 
and that they are empirically frequently 
considered for patients with acute 
hemorrhagic diarrhea (WHO, 1993). All the 
patients were administered at least one 
antimicrobial agent; however, there was no 
documented evidence (bacteriology result) 
to show that any of them had bacterial 
infection. Again, this study shows that of the 
1050 antibiotics prescriptions, gentamicin 
ranked highest, accounting for 23.4% (250). 
This observation, to some extent is at 
variance with Shea et al. (2011) who 
reported that amoxicillin-clavulanate 
(18.3%); cefazolin/cephalexin (18.3%), 
enrofloxacin (16.7%), ampicillin/amoxicillin 
(14.9%) and doxycycline (11.2%) were the 
most frequently prescribed antibiotics in an 
undisclosed small animal clinic in the 
United States of America. However, the 
study was not specific to a disease condition 
as it applies to this study.  
The disrupted intestinal mucosa barrier 
common in dogs with parvovirus enteritis 
predisposes them to a significant risk of 
developing sepsis due to the translocation of 
enteric bacterial organisms and/or toxins 
into the systemic circulation (Kahn, 2010). 
Furthermore, empirical antibiotic therapy 
before culture and sensitivity results is 
frequently considered for patients with acute 
hemorrhagic diarrhea to prevent 
deterioration of symptoms. These to a larger 
extent explain the observation in the present 
study that antibiotics medications were not 
guided by culture and sensitivity. In 
addition, the non-availability of functional 
diagnostic laboratories in majority of these 
veterinary centers, including the Veterinary 
Teaching Hospitals, and/or the associated 
cost when most clients may not be willing or 
unable to incur the financial cost, could have 
been additional contributing factors. 
The choice of antibiotics may perhaps be 
informed by clinical presentation, culture 
and sensitivity result, spectrum of activity, 
safety, availability and cost. The high cost 
and scarcity of amikacin, cefazolin and 
ceftriaxone might have contributed to their 
low prescription rates observed even though 
they are as well effective as gentamicin and 
amoxicillin which are readily available and 
comparatively cheaper. Enrofloxacin, a 
fluoroquinolone for animals exclusively, is 
well known to cause damage to growing 
cartilage (erosive arthropathies), thus 
contraindicated in growing animals (Brown, 
1980). This study has demonstrated that the 
average age of dogs managed for CPE was 
5.9 months indicating that most of them 
were growing puppies. This perhaps could 
reasonably explain its very low prescription 
rate as observed, even though it is known to 
be an effective wide-spectrum bactericidal 
antibiotic for treating mixed infections 
(Vancutsem et al., 1990). One of the 
protozoan infections commonly associated 
with CPE is Giardia spp which 
metronidazole remains a mainstay drug for 
treatment (Vesy and Peterson, 1999; Kahn, 
2010). This again explains the observed high 
prescription frequency of this agent for this 
population. Again, metronidazole is an 
antimicrobial agent used in the treatment of 
anerobic infections, including Clostridia spp 
which is associated with CPE (Lamp, 1999). 
Amoxicillin is one of the antibiotics of 
choice for an “unknown target infection” 
because it is relatively safe, inexpensive 
with a relatively broad spectrum of activity. 
Thus, these make it an antibiotic of choice 
for empirical use (Black et al., 2009; Shea et 
al., 2011). This possibly explains why it was 
among the five most prescribed antibiotics 
for dogs with CPE.  
Concurrent intestinal parasite burden such as 
helminths, Giardia spp or Eimeria spp act as 
additional stress factors and can potentially 
worsen the severity of CPE (Prittie, 2004). 
These intestinal parasites have also been 
reported to enhance intestinal cell turnover,
 
thereby increasing the rate of parvovirus 
infection with consequent intestinal 
epithelial cells destruction (Humm and 
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Hughes, 2009). It is therefore imperative to 
identify and eliminate these parasites. 
However, this study revealed that only 
16.0% of the cases were prescribed 
anthelmintics, thus implying inadequate or 
under prescription.  
Hydrated aluminum silicate (kaolin) has 
been traditionally used internally to control 
diarrhea. When administered orally, it 
adsorbs substances from the gastrointestinal 
tract and increases the bulk of feces 
(Bowman, 2012). Anti-diarrheal 
preparations containing kaolin have been 
used in the treatment of enteritis, cholera, 
and dysentery but not recommended as a 
sole agent in treating infectious diarrhea 
since it has no intrinsic antibacterial activity 
(Kahn, 2010). Nevertheless, enteral 
administrations have been reported to be 
effective in the treatment of systemic 
endotoxemia in an animal model (Gardiner 
et al., 1993). This study revealed that kaolin 
was never prescribed without antibiotics in 
any of the cases. The highest prescription 
rate of kaolin when compared with other 
gastrointestinal modulating drugs observed 
in this study could be to prevent the apparent 
endotoxemia by adsorbing endotoxins 
produced by enteric bacteria organisms, and 
dehydration due to diarrhea common in dogs 
with CPE. Although there is no clinical 
report establishing the clinical benefit for 
their use in the management of diarrhea in 
animals, it is often given to small animals, 
such as foals, calves, lambs as well as kids 
at a recommended dose of 1-2mL/kg per os 
4 times daily (Kahn, 2010). Kaolin is highly 
insoluble and is not absorbed systemically, 
for this reason it is not usually associated 
with severe toxicity. Consequently, the 
administration of mist kaolin orally for 
controlling diarrhea and possible reduction 
of endotoxemia in dogs with CPE as 
observed is appropriate. 
Ranitidine is a substituted aminoalkylfuran 
compound that is a selective and competitive 
antagonist of histamine-2 (H2) receptors in 
the gastric parietal cells resulting in 
decreased gastric acid secretion triggered by 
histamine (Brittain and Daly, 1981; Broqden 
et al., 1982; Hoogerwerf and Pasricha, 
2001). It is therefore used as an anti-ulcer 
drug in human and animals. At present, H2-
receptors are known to be significantly 
distributed only on the parietal cells of the 
gastric mucosa, mast cells, cardiac muscles 
and the lungs (Parsons and Ganellin, 2006; 
Naoyuki et al., 2014).  Also, there is no 
empirical report describing direct or indirect 
involvement of H2-receptor in the 
pathogenesis of parvovirus enteritis and 
involvement of the gastric mucosae other 
than its effect on small intestines. 
Consequently, prescription of ranitidine for 
parvovirus enteritis as observed in this study 
is irrational. This is because gastrointestinal 
tract pathologic lesion in CPE is mainly 
restricted to the small intestine characterized 
by erosion of the intestinal epithelial cells 
(Black et al., 1979; Otto Drobatz, 1997). In 
addition, considering the pharmacoeconomic 
aspect, its prescription in this population 
will be an unnecessary additional cost to the 
client.  
Persistent vomiting common in parvovirus-
infected dogs leads to fluid and electrolyte 
loss, interferes with nutritional support, 
precludes oral administration of 
medications, and puts the patient at risk of 
pneumonia and esophagitis (Kahn, 2010). 
Anti-emetic medications, including 
metoclopramide are therefore essential to 
avert the associated severe emesis in 
addition to limiting the preceding nausea, 
consequently, the patient is able to resume 
eating at an earlier stage of the disease. 
However, this study shows that antiemetics 
accounted for only 8.5% of the total drug 
categories commonly administered to dogs 
with CPE. Since majority of the cases were 
presented with vomiting, antiemetics were 
generally under-prescribed in this 
population. Dogs with CPE often exhibit 
significant visceral pains, with ileus being a 
common differential diagnosis. This requires 
the use of analgesics to control the 
Nigerian Veterinary Journal 38(3). 2017 Gberindyer et al 
   
257 
 
abdominal pain.  However, non-steroidal 
anti-inflammatory drugs (NSAIDs) are 
contraindicated for pain management in 
dogs with parvovirus enteritis because of 
their ulcerogenic potential and the fact that 
they increase the risk of acute renal injury in 
dehydrated patient (Tripathi, 2008), which is 
consistent in dogs with parvovirus enteritis. 
Result from this study demonstrated that all 
the analgesics used were NSAIDs, mostly 
piroxicam, diclofenac and ibuprofen. This 
demonstrates irrational drug use in this 
clinical condition. Opioids, such as fentanyl 
are the preferred analgesics, however higher 
doses could worsen ileus and cause sedation. 
Effective therapeutic dose regimen of 
gentamicin for dogs is 6-12mg/kg to be 
administered once daily, by intramuscular or 
intravenous route (Kahn, 2010). In order to 
minimize adverse effects and optimize 
efficacy, treatment duration not exceeding 5 
days had been recommended (Gberindyer et 
al., 2015). However, the present study 
revealed that of the 250 gentamicin 
prescriptions for dogs with CPE, 57.0% 
were below 6mg/kg body weight, indicative 
of under-dosing. Nevertheless, 30.0% of the 
administered doses were within the 
recommendation. This in addition has 
demonstrated the irrational practice in 
respect to dose regimen. This could be due 
to the fear of adverse effects (nephrotoxicity 
and ototoxicity) commonly associated with 
gentamicin. Under-dosing of antibiotic, 
which constitute irrational antibiotic use 
could result in therapeutic failure and 
emergence of drug resistant bacterial strains 
due to under-exposure. Thus, the study has 
sufficiently demonstrated that there is 
generally poor prescription attitude in the 
management of CPE in the study locations. 
This mostly involved management of the 
associated secondary bacterial infections, 
diarrhea, vomiting and pain. 
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